CAPUCCI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 8.688
EU - Europa 4.868
AS - Asia 3.562
SA - Sud America 934
AF - Africa 341
Continente sconosciuto - Info sul continente non disponibili 249
OC - Oceania 8
Totale 18.650
Nazione #
US - Stati Uniti d'America 8.528
RU - Federazione Russa 1.384
SG - Singapore 1.175
VN - Vietnam 838
BR - Brasile 737
UA - Ucraina 679
IT - Italia 610
CN - Cina 535
DE - Germania 440
IE - Irlanda 401
SE - Svezia 299
FR - Francia 260
HK - Hong Kong 247
DK - Danimarca 220
TR - Turchia 197
GB - Regno Unito 187
FI - Finlandia 178
MA - Marocco 150
KR - Corea 119
IN - India 102
CI - Costa d'Avorio 99
BD - Bangladesh 85
CA - Canada 72
AR - Argentina 68
MX - Messico 48
NL - Olanda 48
IQ - Iraq 40
JP - Giappone 39
ZA - Sudafrica 35
EC - Ecuador 33
ES - Italia 32
PL - Polonia 31
CO - Colombia 26
ID - Indonesia 25
PK - Pakistan 24
VE - Venezuela 21
AT - Austria 19
BE - Belgio 19
TN - Tunisia 15
UZ - Uzbekistan 15
CL - Cile 13
JO - Giordania 13
EG - Egitto 12
EU - Europa 12
TH - Thailandia 12
CZ - Repubblica Ceca 11
KZ - Kazakistan 11
PE - Perù 11
PH - Filippine 11
RS - Serbia 11
SA - Arabia Saudita 11
MY - Malesia 10
PY - Paraguay 10
RO - Romania 10
CR - Costa Rica 9
AE - Emirati Arabi Uniti 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
BO - Bolivia 6
DZ - Algeria 6
IL - Israele 6
JM - Giamaica 6
SN - Senegal 6
AU - Australia 5
LB - Libano 5
NP - Nepal 5
BH - Bahrain 4
HN - Honduras 4
KE - Kenya 4
LT - Lituania 4
PR - Porto Rico 4
PT - Portogallo 4
AZ - Azerbaigian 3
BG - Bulgaria 3
HU - Ungheria 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
Totale 18.402
Città #
Ashburn 1.158
Singapore 748
Jacksonville 712
Chandler 664
Fairfield 556
Dublin 396
Boardman 376
Council Bluffs 367
Dallas 334
New York 315
San Jose 307
Ho Chi Minh City 260
Wilmington 245
Hong Kong 238
Seattle 214
Woodbridge 212
Houston 205
Hanoi 195
Cambridge 182
The Dalles 178
Beijing 156
Lawrence 149
Princeton 149
San Mateo 144
Lauterbourg 142
Los Angeles 132
Ann Arbor 116
Abidjan 99
Moscow 94
Hefei 90
Des Moines 84
Munich 75
San Diego 73
São Paulo 65
Milan 55
Turin 54
Chicago 51
London 49
Ancona 44
Da Nang 44
Buffalo 42
Centro 40
Santa Clara 40
Haiphong 34
Helsinki 34
Turku 34
Frankfurt am Main 32
Orem 32
Tokyo 32
Pune 31
Miano 28
Warsaw 26
Belo Horizonte 24
Montreal 24
Rio de Janeiro 24
Amsterdam 23
Atlanta 23
Phoenix 23
Denver 21
Norwalk 21
Washington 21
Brasília 20
Chennai 20
Salt Lake City 20
Hải Dương 19
Brussels 18
Johannesburg 18
Nuremberg 18
Rome 17
Baghdad 16
Poplar 16
Stockholm 16
Salvador 15
Shanghai 15
Brooklyn 14
Guangzhou 14
Mumbai 14
Porto 14
Toronto 14
Amman 13
Tashkent 13
Biên Hòa 11
Guayaquil 11
Manchester 11
Mexico City 11
Quảng Ngãi 11
Redmond 11
Vienna 11
Campinas 10
Can Tho 10
Curitiba 10
Lahore 10
Tampa 10
Belgrade 9
Bogotá 9
Cape Town 9
Elk Grove Village 9
Olomouc 9
Porto Alegre 9
Quận Ba 9
Totale 10.850
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 842
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. 254
Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients with Takotsubo Syndrome 230
Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on a Tertiary-Level Electrophysiology Laboratory in Italy 183
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 173
Procedural sedation for direct current cardioversion: a feasibility study between two management strategies in the emergency department 165
Flecainide: Electrophysiological properties, clinical indications, and practical aspects 163
Dronedarone: a real innovation or a mere second-best choice? How to find the way among guidelines, regulatory agencies and daily clinical practice 156
An Unusual Left Atrial Mass in a Woman with Active Breast Cancer and Recent Cardiothoracic Surgery 155
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 154
Tachycardiomyopathy in Patients without Underlying Structural Heart Disease 154
Incidence and risk of cardiotoxicity in cancer patients treated with targeted therapies 153
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 152
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 150
Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers. 149
'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? 147
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 147
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 143
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments 142
Comorbidities frequency in takotsubo syndrome: An international collaborative systematic review including 1109 patients 140
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 139
A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I 139
Cardioembolism and takotsubo syndrome: A case report 137
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 137
Amiodarone and digitalis: An odd couple in a tachycardiomyopathic patient 136
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. 135
Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. 133
New anthyarrhythmic drugs for atrial fibrillation 131
Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD) 130
Subclinical progression of systemic sclerosis-related cardiomyopathy 129
A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. 129
Dr. Guerra, et al reply 128
Coronary Spasm and Inflammation: Can We Kill 2 Birds With 1 Stone? 128
Incidence and Clinical Impact of Recurrent Takotsubo Syndrome: Results From the GEIST Registry 128
Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. 127
Global Longitudinal Strain as a Predictor of First and Subsequent Arrhythmic Events in Remotely Monitored ICD Patients With Structural Heart Disease 127
Takotsubo syndrome in the paediatric population: A case report and a systematic review 125
Subclinical atrial fibrillation and the risk of stroke 124
Safety and tolerability of a cardiologist-only approach to sedation for electrical cardioversion in the Emergency Department: The INSTEAD pilot trial 124
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD) 124
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey. 123
Letter by Ciliberti and Capucci regarding article, "medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease" 123
Temporal relationship between subclinical atrial fibrillation and embolic events 123
ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT). 122
Clinically guided pacemaker choice and setting: pacemaker expert programming study 122
Antiarrhythmic drugs for atrial fibrillation. 122
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 118
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis 118
[Early and mid-term results of the transapical aortic valve Symetis Acurate TA: a viable solution in high-risk patients with severe vascular disease] 118
The ECG in the differential diagnosis between takotsubo cardiomyopathy and acute coronary syndrome 117
Current Therapeutic Options for Heart Failure in Elderly Patients 117
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry 117
Atrial Fibrillation and Congestive Heart Failure: should we aim to control the heart's rate or its rhythm? 116
Flecainide-metoprolol combination reduces atrial fibrillation clinical recurrences and improves tolerability at 1-year follow-up in persistent symptomatic atrial fibrillation 116
Cardiomyopathy induced by frequent premature ventricular complexes originating from the right ventricular outflow tract: left ventricular systolic function recovery after transcatheter ablation. 115
Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation 115
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. 115
Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE). 114
IntErnationaL eLeCTRicAl storm registry (ELECTRA): Background, rationale, study design, and expected results 114
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy 114
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 114
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation. 113
Endocardial defibrillation lead extraction: an unusual case of entrapment. 113
Is there an 'atherosclerotic continuum' from angina with unobstructed coronary arteries to MINOCA? 113
Transient QRS amplitude attenuation is associated with clinical recovery in patients with takotsubo cardiomyopathy 112
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. 111
New insights into the initiation of atrial fibrillation: a detailed intraindividual and interindividual analysis of the spontaneous onset of atrial fibrillation using new diagnostic pacemaker features. 110
Hospitalization in ICD recipients. 110
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation. 109
Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents 109
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). 109
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: A randomized, open-blinded, prospective study 109
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 109
Capture of atrial fibrillation reduces the atrial defibrillation threshold. 108
Out-of-hospital cardiac arrest and public access defibrillation. 107
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 106
Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. 106
Cardiac resynchronization therapy improves ejection fraction and cardiac remodelling regardless of patients' age 106
Community-based automated external defibrillator only resuscitation for out-of-hospital cardiac arrest patients 106
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. 106
The role of EP-guided therapy in ventricular arrhythmias: beta-blockers, sotalol, and ICD's. 105
Electrical storm and heart failure worsening in implantable cardiac defibrillator patients 105
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure. 105
Intravenous vernakalant for the rapid conversion of recent onset atrial fibrillation: systematic review and meta-analysis 104
Omega-3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet? 104
Temporal trends and temperature-related incidence of electrical storm: The TEMPEST Study (Temperature-related incidence of electrical storm) 104
Rebuttal of critique of Progetto Vita survival data 104
Sedation in cardiac arrhythmias management 103
Memorizzazione a distanza dei contenuti teorici derivati dai corsi BLS e BLS-D 103
Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study 103
Racial and Ethnic Differences in Electrocardiographic Features of Takotsubo Cardiomyopathy 102
Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. 101
Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring 101
Indications for implantable cardioverter defibrillator (ICD) therapy. 100
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis 100
Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: The ALPHEE study 100
Is invasive coronary provocation testing cost-effective among MINOCA patients? 100
Emerging pharmacotherapies for the treatment of atrial fibrillation 100
Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs. 100
Entirely Subcutaneous Implantable Defibrillator: Safest Option in a Young Girl With Ventricular Tachycardia and Ebstein Anomaly 100
Totale 13.151
Categoria #
all - tutte 93.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.017 0 287 33 25 28 48 73 68 66 71 121 197
2022/20232.113 175 223 146 168 161 281 7 106 469 46 254 77
2023/20241.346 254 48 97 186 233 297 18 36 12 24 15 126
2024/20252.382 191 330 104 18 74 61 128 94 579 167 263 373
2025/20267.157 458 389 385 868 632 442 1.155 703 1.140 526 136 323
2026/2027516 367 149 0 0 0 0 0 0 0 0 0 0
Totale 18.650